Navigation Links
Access to existing medical treatments could save more lives than spending to improve the treatments

More lives could be saved in the United States by spending less money on making medical treatments better and more on getting existing treatments to the patients who need them, according to a study published by a Virginia Commonwealth University family medicine and public health physician.

"For every dollar Congress gives the National Institutes of Health to develop blockbuster treatments, it spends only one penny to ensure that Americans actually receive them," said Steven H. Woolf, M.D., professor and director of research in VCU's Department of Family Medicine and a member of the National Academy of Sciences' Institute of Medicine. "This reflects, in part, a misperception that the improved drugs, procedures and the like will improve health outcomes, and that does happen. But the health improvement would be far greater if we worried less about making incremental improvements on existing treatments and more on the system barriers that impede Americans from receiving those treatments correctly." The study was coauthored by Robert E. Johnson, Ph.D., an associate professor in VCU's Department of Biostatistics.

Woolf and Johnson, whose study appears in the Dec. 6 issue of the Annals of Family Medicine, said a mathematical construct proves the point. They used two case studies -- one involving statins and the other antiplatelet drugs -- to show that the billions of dollars spent on new generation drugs saved fewer lives and prevented fewer strokes than if the existing drugs had been taken by all patients who could benefit. They cited reports that Americans receive only half of recommended health care services and that disparities in care are worse for minorities and disenfranchised patients.

The study poses a contrast between efficacy, or how well a treatment works, and what they call the "fidelity of health care." Independent of the efficacy, fidelity is the extent to which the health care system provides patients the precise interventions they ne
'"/>

Source:Virginia Commonwealth University


Page: 1 2 3

Related biology news :

1. Open Access journals get impressive impact factors
2. Access to antiretrovirals unlikely to reduce HIV infection rates
3. Gadonanotubes greatly outperform existing MRI contrast agents
4. Automatic extraction of gene/protein biological functions from biomedical text
5. Vital step in cellular migration described by UCSD medical researchers
6. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
7. UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints
8. Innovative coating could give medical implants a longer life
9. Natural tumor suppressor in body discovered by UCSD medical researchers
10. Protein synthesis can be controlled by light, opening way for new scientific, medical applications
11. Modified collagen could yield important medical applications
Post Your Comments:
(Date:12/3/2009)... International, Inc. (OTC Bulletin Board: BKYI), a leader ... solutions, announced that a majority of its shareholders ... the sale of the company,s Law Enforcement Division ... voted, 98.6% were cast in favor and 1.2% ...
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... Van Andel Research Institute (VARI) researchers have determined ... the molecular level to help plants respond to environmental stresses ... the journal Nature , could help engineer crops that ... food shortages. The findings could also have implications for ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3The white stuff 3A Marine lab team seeks to understand coral bleaching 10476 1The white stuff 3A Marine lab team seeks to understand coral bleaching 10476 2Geologist analyzes earliest shell covered fossil animals 10474 1Geologist analyzes earliest shell covered fossil animals 10474 2CT Scans Surpass X Rays for Swine Flu 3A Study 59945 1
... ARBOR, Mich.---Two species of giraffe, several rhinos and five ... horses, antelope and apes, once inhabited what is now ... some 8 million years ago, precipitating a major change ... adapting to the new ecosystem, according to an extensive, ...
... Stanford, CAHow much carbon dioxide is too much? According ... greenhouse gases in the atmosphere need to be stabilized ... with the climate system." But scientists have come to ... change is lurking in the world,s oceansone that is ...
... members at the University of California, San Diego have ... Health, awards intended to accelerate the translation of cutting-edge ... , Karen Christman, assistant professor of bioengineering at ... Seth J. Field, an assistant professor of medicine at ...
Other Biology News:Long-term study shows effect of climate change on animal diversity 2Modest CO2 cutbacks may be too little, too late for coral reefs 2NIH doles out $3M in new innovator awards to 2 UC San Diego faculty 2
(Date:12/4/2009)... Dec. 4 Stemline Therapeutics, Inc. today announced that data ... SL-501, in both in vitro and animal models ... poster presentation at the upcoming 51st Annual Meeting of the ... Orleans from December 5-8, 2009. The poster will be presented ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. (OTC ... European commercial launch of MuGard, an FDA approved treatment ... treatment and chemotherapy. MuGard is commercially launched by Access, ... Germany, Italy, Norway, Greece and Sweden. Access is conducting ...
(Date:12/3/2009)... Dec. 3 Inverness Medical Innovations, Inc. (NYSE: ... charge of their health at home through the merger of ... $3.00 per share on its Series B Convertible Perpetual Preferred ... of Series B stock in an amount per share equal ...
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the fastest ... of True Green Energy Group and True Green Planet,s President ... recycling business for over 25 years, stated that Spectrum Blue ... the stage for spectacular earnings because of the bi products ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3
... STATESVILLE, N.C., Aug. 22 Kewaunee,Scientific Corporation (Nasdaq: ... first,quarter ended July 31, 2007 and the declaration ... the quarter were $674,000, or $0.27 per diluted ... $0.05 per diluted share, for,the first quarter of ...
... August 22 Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader ... it will release its financial results for the first,six ... 8 am Central European,Time (CET). To discuss these ... am CET. Netherlands Dial In: +31-800-949-4517 (toll free); US ...
... Aug. 21 Zyvex Labs today announced,its first ... started by Rob,Burgess, PhD, former Vice President of ... PhD, former Group Leader of Life Sciences,at Zyvex ... of nanotechnology in Life,Sciences. The company seeks to ...
Other Biology Technology:Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend 2Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend 3Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend 4NanoMed, Inc. Spins Out of Zyvex Labs 2
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rab1A...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Biology Products: